US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.36

+0.11000.32%

Volume:14.87K

Turnover:511.72K

Market Cap:95.52M

PE:- -

High:34.62

Open:34.39

Low:34.20

Close:34.25

52wk High:36.84

52wk Low:23.42

Shares:2.78M

Float Shares:2.78M

Volume Ratio:0.73

T/O Rate:0.53%

Dividend:0.26

Dividend Rate:0.75%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Intel, Amgen, Novartis, Bloom Energy, and More Stocks That Explain Today's Market

Beneath the Surface, the Next Market Leaders are Getting Ready to Break Out, Says Morgan Stanley

Ionis Pharma Tumbles After Heart Drug Fails Late-Stage Trial

Why Amgen Stock is Dropping After Swiss Rival's Trial Setback

Cholesterol Drug Trial Setback Casts Doubt on Multi-Billion Rivalry

Amgen Falls After Novartis Trial Setback, BMO Downgrade

Fosun Pharma's Subsidiary Obtains Regulatory Nod for FXS5626 Tablet Trial in Vitiligo Indication

Stocks to Watch: Amgen, Nike, Bloom Energy

Pharmaceutical Giant's Shares Plunge Nearly 10% Following Triple Clinical Trial Setbacks

Medprin Regenerative Medical Technologies Advances Absorbable Hemostatic Gel to Clinical Trials

Amgen Shares Down 5.4% Premarket; Rival Novartis Cholesterol Drug Fails Late-Stage Study

THOMSON REUTERS

Why the Dow is Being Dragged Down by a Swiss Company's Bad News

Milton Essex boosts Sanford Biotech capital to drive advanced mastitis cell therapy

Gilead Sciences (GILD) Receives a Buy from Bernstein

Jiangsu Aidea Pharmaceutical to Join Specialised Earnings Briefing for Innovative Drug Firms on STAR Market

CSPC Pharma Initiates Phase II Trial of SYH2085 Tablet for Uncomplicated Influenza in Chinese Adults

Remegen Announces Participation in Nasdaq-Style STAR Market Biopharma Sector Earnings Conference

HENGRUI PHARMA Advances Pipeline with SHR-1179 Injection Clinical Trial Approval

Hengrui Pharma Subsidiary Gains Clinical Trial Approval for Weight Management Drug Candidate

Chongqing Zhifei Biological Receives Clinical Trial Approval for Recombinant Rotavirus Subunit Vaccine

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/IBBQ/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":34.36,"timestamp":1789588513736,"preClose":34.25,"halted":0,"volume":14867,"delay":0,"changeRate":0.0032116788321167717,"floatShares":2780001,"shares":2780001,"eps":0,"marketStatus":"Trading","change":0.11,"latestTime":"09-16 15:55:36 EDT","open":34.39,"high":34.62,"low":34.1992,"amount":511723.62669999996,"amplitude":0.012286,"askPrice":34.38,"askSize":4200,"bidPrice":34.35,"bidSize":1300,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":34.25,"sharesOutstanding":2520001,"nav":34.76286,"aum":96640785.56286,"dividendRate":0.007477,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":34.28,"preClose":34.25,"latestTime":"09:29 EDT","volume":69,"amount":2360.8497660000003,"timestamp":1789565397037,"change":0.03,"changeRate":0.000876,"amplitude":0.008175},"postHourTrading":{"tag":"盘后","latestPrice":34.25,"preClose":34.25,"latestTime":"19:30 EDT","volume":6387,"amount":218773.45,"timestamp":1789515006181,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.725228,"impliedVol":0.0643,"impliedVolPercentile":0.0598},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":2780001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.725228,"shares":2780001,"dividePrice":0.2569,"high":34.62,"amplitude":0.012286,"preClose":34.25,"low":34.1992,"week52Low":23.42,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":34.36,"committee":-0.527273,"eps":0,"divideRate":0.007477,"volume":14867,"delay":0,"ttmEps":0,"open":34.39,"prevYearClose":28.3962,"prevWeekClose":34.472,"prevMonthClose":35.4742,"prevQuarterClose":32.66,"fiveDayClose":34.9277,"twentyDayClose":34.6197,"sixtyDayClose":30.4995},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"IBBQ","amount":0.0287,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665932217","title":"Intel, Amgen, Novartis, Bloom Energy, and More Stocks That Explain Today's Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2665932217","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665932217?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:05","pubTimestamp":1788865500,"startTime":"0","endTime":"0","summary":"Stock futures were dropping on Tuesday as oil prices neared $100 a barrel, bolstering the case for the Federal Reserve to hike interest rates next week.Artificial-intelligence stocks were rising despite the market's inflation worries. Chip maker Intel was the S&P 500's top performer ahead of the opening bell, advancing 3.6%. Advanced Micro Devices, Marvell, Micron, and Sandisk were also up in premarket trading.Amgen fell 4.9% after drugmaker Novartis reported disappointing trial results for its experimental cardiovascular treatment, pelacarsen. Amgen is developing a treatment of its own called olpasiran. Novartis' Swiss-listed shares dropped 9.1% following a series of trial setbacks.Fuel-cell manufacturer Bloom Energy jumped 5.9%, data storage company Everpure added 3%, and biotech Illumina ticked up 0.9%. The stocks are set to join the S&P 500 before trading opens on Sept. 21.Building supplier Builders FirstSource, brewer Molson Coors Beverage, and advertising software company Trade D","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0444971666.USD","LU0109394709.USD","AMGN","LU2473716301.USD","SMOG","LU1804176565.USD","GAMR","BK4534","LU2355687059.USD","XNTK","LU2089984988.USD","LU2506951792.HKD","LU2764263203.CNY","LU0823421416.USD","LU1992135472.HKD","AMYY","IE0004086264.USD","BK4512","LU1720051017.SGD","USXF","LU2896262040.SGD","BK4575","INYY","LU2272731600.USD","LU2720916845.USD","BK4121","LU0719512351.SGD","LU1880398554.USD","LU0109392836.USD","AIQ","IE00BLSP4239.USD","LU2272731782.SGD","QQQA","BK4579","LU1861215975.USD","LU2860962120.EUR","SINTCmain","AMDY","IE00BZ1G4Q59.USD","LU1303367103.USD","LU0122379950.USD","LU2108987350.USD","LU2264538146.SGD","LU2249611893.SGD","LU0390134368.USD","IE00BJJMRZ35.SGD","LU2357627491.SGD","LU1061106388.HKD","LU0082616367.USD","LU2357125470.USD","LU1861220033.SGD","ILMN","BEC","IE000F7OJYX1.SGD","LU1057294990.SGD","LU0823434740.USD","SGXZ51526630.SGD","IE0004445239.USD","LU1064131342.USD","LU2931357623.SGD","BK4533","BK4182","LU2462591350.SGD","BEX","TTD","BK4581","PBE","INTW","BK4141","ICLN","LU0251142724.SGD","MRVU","IE00BLSP4452.SGD","LU1852331112.SGD","LU2458330169.SGD","BK4605","IE000SO60NU8.SGD","IE00BQXX3C00.GBP","BK4528","GTEK","BK4602","LU1989764664.SGD","FXL","BAI","LU2461242641.AUD","IE00B4R5TH58.HKD","MRVX","LU1548497426.USD","IE00BJT1NW94.SGD","LU2322448791.USD","BK4515","LU1023059063.AUD","VCLN","LU1988902786.USD","BK4585","LU1169589451.USD","LU2250418816.HKD","INT","04335","INTC","LU2089985449.USD","LU2458330243.SGD","AMDU","BK4588","LU2417539215.USD","IE0009356076.USD","BE","AIS","IE00BKVL7J92.USD","LU1861558580.USD","SMH","MVLL","BK4573","IE00BMPRXR70.SGD","LU2294711713.HKD","DTCR","LU1923623000.USD","LU2468319806.SGD","LU1261432733.SGD","LU2272731865.HKD","SOXY","IE00BQXX3F31.USD","LU2098885051.SGD","TTEQ","BEG","LU0061475181.USD","SMHX","LU0823421333.USD","TEK","LU0444973449.USD","FTXL","LU0174119429.USD","AMDG","LU1803068979.SGD","IE00B5949003.HKD","LU0889565916.HKD","LU1880398471.USD","IBBQ","LU0742534661.SGD","LU0058720904.USD","LU1084165304.USD","IE00B1BXHZ80.USD","IE0000B7K699.USD","LU2361044949.HKD","LU2242652126.USD","BK4614","BK4550","AMDW","WATS","LU0289739699.SGD","IE00BQXX3D17.EUR","LU1720051108.HKD","LU1983299246.USD","AMDL","LU0979878070.USD","LU2148611432.USD","BK4529","LU2112291526.USD","LU0320765992.SGD","LU2360106780.USD","UPGR","BK4548","LEGR","IBAT","FRNW","LU2764263039.SGD","IE00BMPRXN33.USD","HK0000304797.USD","LU0251131958.USD","LU1119994496.HKD","CHAT","LU0128526141.USD","IE0009354923.USD","BK4541","LU1989772923.USD","IE00BMPRXQ63.HKD","LU2236285917.USD","LU0274383776.USD","PJP","BK4527","CHPS","LU0210536198.USD","LU1951198990.SGD","LU1815336760.USD","LU2054465674.USD","LU1169590202.USD","LU1823568750.SGD","LU0889565833.HKD","LU2361045086.USD","VTWG","AMDD","LU1571399168.USD","SGXZ81514606.USD","LU0792757196.USD","LU1235294995.USD","CTEC","IETC","LU1989764748.USD","04332","BK4543","IBB","LU2322448957.HKD","LU2242649171.HKD","LU2242646821.SGD","ILDR","IE000M9KFDE8.USD","LU0321505868.SGD","LU1316542783.SGD","BIB","LU0127658192.USD","LU1642822529.SGD","AMUU","MRVL","AMD","DRIV","SOXX","PSI","TBXU","ZAP","LU0859254822.USD","BK4532","LU0823414478.USD","HK0000304805.HKD","LU2456880835.USD","LU0957808578.USD","IE000WAW04H5.SGD","LU0786609619.USD","BK4007","GNMX","BK4139","LU1861559042.SGD","LU2290526834.HKD","WISE","EGGY","FAI","AIFD","TRFK","LU0048573561.USD","SGXZ99366536.SGD","LU1242518857.USD","IE00BN8TJ469.HKD","LU0321505439.SGD","IE00BBT3K403.USD","ARTY","BEZ","BK4613","LU0056508442.USD","LU2361044865.SGD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0889566641.SGD","LU1046421795.USD","BK4009","DAMD","BBH","BK4604","LU0029874061.USD","LU0476273544.USD","TTDU","SAMD0main","LU0048584097.USD","BK4535","LINT","BK4554","LU2357305700.SGD","FDTX","SIMS","LU0187121727.USD","LU1992135399.USD","SG9999001424.SGD","WUGI","LU2764262908.HKD","BK4612","IE0001KFT4U8.USD","IE00B2B36J28.USD","LU1242518931.SGD","AMDC","LU2543165471.USD","LU0348723411.USD","LU0154236417.USD","SG9999000418.SGD","LU0823414551.USD","BK4599","LU2360107168.USD","LU0133085943.USD","BK4023","LU2244417387.USD","LU0868494617.USD","LU0081259029.USD","CNRG","LU0097036916.USD","IE0002141913.USD","LU0149725797.USD","GNOM","IE000BZT7R73.USD","IE000MB6IJN5.SGD","LU0823434583.USD","AMDS","BK4566","LU1951200564.SGD","LU2265009873.SGD","IE0004091025.USD","LU0198837287.USD","LU1232071149.USD","LU0251132253.USD","SG9999001440.SGD","LU1267930813.SGD","LU1989772840.SGD","LU0642271901.SGD","NVSEF","LU2247934214.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665617322","title":"Beneath the Surface, the Next Market Leaders are Getting Ready to Break Out, Says Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2665617322","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665617322?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:56","pubTimestamp":1788864960,"startTime":"0","endTime":"0","summary":"Morgan Stanley says conditions are ripe for software, healthcare and bank stocksMorgan Stanley says a new class of stocks is getting ready to emerge.Labor Day marks the final stretch of what's been a pretty good year for stocks. The S&P 500 SPX is up 14% this year, the small-cap Russell 2000 RUT has gained 20%, semiconductor stocks SOX have soared, basically everything but the Magnificent Seven is returning double digits.Stock-market strategists at Morgan Stanley led by Mike Wilson said that performance is no accident. \"This has all coincided with what we have deemed a new economic cycle that began at the trough of the rolling recession around Liberation Day in April 2025. The reacceleration in sales growth has led to a V-shaped rebound in EPS [earnings per share] growth as operating leverage returned to the median company,\" they say.But the one part of the market that has cooled are so-called momentum stocks, whose precise definitions vary but basically are bets that fast-rising stock","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0164881194.USD","LU1989772923.USD","LU0267386448.USD","IBB","IE00B2B36J28.USD","KBWB","LU0158827781.USD","LU0225283273.USD","LU2468319806.SGD","BK4523","TBXU","IE00BJT1NW94.SGD","NVS","BK4532","BK4599","IE00B775SV38.USD","LU1791710400.SGD","PPH","EQRR","CGDV","BK4566","MEDX","RULE","BAMA","LU0210528500.USD","QTOC","LU0122379950.USD","IE00BYTNYM70.SGD","BIB","EDOG","SG9999001440.SGD","PBE","IAI","VTV","IMCG","HIDV","LU0868486357.SGD","IBBQ","FT","PJP","IE00B3S45H60.SGD","LU1023059063.AUD","BBH","IE00BFTCPJ56.SGD","BK4127","INFY","AMGN","LU2242652126.USD","BK4535","PLGI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665839324","title":"Ionis Pharma Tumbles After Heart Drug Fails Late-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665839324","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665839324?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:22","pubTimestamp":1788862967,"startTime":"0","endTime":"0","summary":"BUZZ-Ionis Pharma tumbles after heart drug fails late-stage trial** Ionis Pharmaceuticals'IONS.Oshares fall 12.7% to $50.70 premarket** NovartisNOVN.Sand Ionis said late Friday their experimental drug pelacarsendid not cutthe risk of major heart attacks and strokes in patients with a genetic risk factor in a late-stage trial** The drug successfully lowered a dangerous genetic cholesterol, Lp, but it did not improve overall heart health outcomes** The trial failure was negative for biopharma sector perception because lowering Lp \"did not reduce cardiovascular events in the overall population\", say analysts at Leerink Partners**Amgen'sAMGN.Oand Eli Lilly'sLLY.Ndrugs \"lower Lp more than pelacarsen\" and could now facegreater scrutiny- brokerage** Amgen shares slip 5% to $415.01 before the bell** As of last close, IONS down 26.6% YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4500PU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["04332","IE00B4R5TH58.HKD","LU1571399168.USD","LU0058720904.USD","LU0109394709.USD","IE00BFTCPJ56.SGD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU0320765992.SGD","BK4581","LU0122379950.USD","IE00BJT1NW94.SGD","AMGN","IBBQ","LU0289739699.SGD","BK4139","IE00B2B36J28.USD","SG9999001440.SGD","BBH","PJP","IBB","TBXU","IE0009355771.USD","LU1061106388.HKD","BK4533","LU2242646821.SGD","LU2112291526.USD","IE0002141913.USD","PBE","LU1983299246.USD","BK4588","BK4534","LU0868494617.USD","BK4566","IONS","LU1057294990.SGD","BIB","BK4599","LU1023059063.AUD","BK4585","LU2089984988.USD","LU2468319806.SGD","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665147329","title":"Why Amgen Stock is Dropping After Swiss Rival's Trial Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2665147329","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665147329?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:53","pubTimestamp":1788861180,"startTime":"0","endTime":"0","summary":"Big Pharma has been scrambling to restock its pipelines this year-so a disappointing trial from one drugmaker can have an outsize knock-on impact for rivals trying to develop similar treatments.That d","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","LU2468319806.SGD","BK4566","BBH","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4534","SG9999001440.SGD","BK4139","BK4533","IBBQ","TBXU","IE00B2B36J28.USD","IE0002141913.USD","LU0122379950.USD","LU1023059063.AUD","BK4599","LU0889565916.HKD","LU2242646821.SGD","BIB","LU0868494617.USD","BK4581","PBE","LU2112291526.USD","LU1061106388.HKD","LU0058720904.USD","BK4588","AMGN","BK4585","LU1057294990.SGD","IBB","LU2242652126.USD","LU1983299246.USD","LU0320765992.SGD","LU0289739699.SGD","LU2089984988.USD","LU0109394709.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU1571399168.USD","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194747479","title":"Cholesterol Drug Trial Setback Casts Doubt on Multi-Billion Rivalry","url":"https://stock-news.laohu8.com/highlight/detail?id=1194747479","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194747479?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:40","pubTimestamp":1788860434,"startTime":"0","endTime":"0","summary":"Novartis's closely watched cardiovascular trial has failed, raising significant questions about one of the pharmaceutical industry's most prominent drug development races and casting uncertainty over...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSYK","MDTX","IBBJ","IBBQ","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665326246","title":"Amgen Falls After Novartis Trial Setback, BMO Downgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2665326246","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665326246?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:27","pubTimestamp":1788859626,"startTime":"0","endTime":"0","summary":"BUZZ-Amgen falls after Novartis trial setback, BMO downgrade** Shares of AmgenAMGN.Oslip 4.8% to $416 premarket** Novartis'NOVN.Scholesterol drug failed in a closely watched study,raising concernsfor ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4500KO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","SG9999001440.SGD","LU0868494617.USD","IE0009355771.USD","LU0320765992.SGD","LU1057294990.SGD","IE00BFTCPJ56.SGD","IBBQ","LU2242652126.USD","LU2112291526.USD","TBXU","BK4139","IBB","LU2089984988.USD","BK4566","BBH","LU1983299246.USD","LU1571399168.USD","LU0109394709.USD","PBE","LU2468319806.SGD","BK4581","AMGN","BIB","IE00B4R5TH58.HKD","BK4599","IE00BJT1NW94.SGD","LU0122379950.USD","LU0289739699.SGD","LU0058720904.USD","LU2242646821.SGD","LU1061106388.HKD","BK4534","LU1023059063.AUD","BK4533","BK4585","BK4588","LU0889565916.HKD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132147233","title":"Fosun Pharma's Subsidiary Obtains Regulatory Nod for FXS5626 Tablet Trial in Vitiligo Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=1132147233","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132147233?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:20","pubTimestamp":1788859248,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SH: 600196) has announced that its controlling subsidiary, Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd., recently received approval...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","MDTX","BK0183","BK1515","BK1593","IBBQ","BMED","600196","PSYK","BK0060","02196","BK0175","BK0188","BK0028","BK0096","BK0239","BK0196","IBBJ","BK0012","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665342326","title":"Stocks to Watch: Amgen, Nike, Bloom Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2665342326","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665342326?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:07","pubTimestamp":1788858420,"startTime":"0","endTime":"0","summary":"Amgen : Shares of the biotechnology company, a major contributor to the Dow, shed more than 5% premarket after the Swiss drugmaker Novartis  said an experimental medicine failed to reduce cardiovascular risk in a late-stage clinical trial. Amgen and Eli Lilly  are working on rival treatments. Novartis shares tumbled 10% in Europe, while Eli Lilly shares ticked down.Bloom Energy : The fuel-cell maker is among the companies that will join the S&P 500 later this month, S&P Dow Jones Indices announced late Friday, sending its shares 4% higher premarket. Meanwhile, Nike  will be deleted from the S&P 100. Its shares edged lower premarket.Coinbase Global , Robinhood Markets , Strategy : Shares of companies tied to cryptocurrencies retreated in premarket trading as bitcoin's price slipped more than 1% to trade below $78,500.GameStop  is set to report earnings after markets close.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","MSST","BK4533","CONX","BK4007","LU0208291251.USD","BK4547","HOOI","MSTZ","AMGN","IE00BJJMRZ35.SGD","GME","LU0310800379.SGD","CTEC","LU0211331839.USD","BEZ","HOOY","HOOG","MEDX","BK4112","LU1303367103.USD","IE00B2B36J28.USD","LU0444973449.USD","NVS","IE00BFXG0V08.USD","IAI","LU1861558580.USD","BK4146","FDIG","HOOX","LU0444971666.USD","BEG","COIW","CONL","BK4599","IBLC","WNTR","MTYY","LU2089984988.USD","LU1267930813.SGD","BK4561","BK4577","LU2357125470.USD","DAPP","BK4554","NKE","APED","BEX","LU2506951792.HKD","PPH","LU1061106388.HKD","ZAP","LU0289739699.SGD","MSTX","FINX","LU1861220207.SGD","IGME","BK4595","BK4588","07399","EGGY","GMEY","IE0009355771.USD","LU0310800965.SGD","LU0889566641.SGD","BE","BK4534","LU0029864427.USD","BEC","BK4182","LU0792757196.USD","LU2264538146.SGD","LU1861217088.USD","LU2249611893.SGD","LU0052756011.USD","MSTK","WATS","BK4581","LU0957808578.USD","FRNW","ICOI","IE00BJT1NW94.SGD","GMEU","BK4127","IMST","BKCH","LU1057294990.SGD","LU0070302665.USD","BK4566","BK4585","CRPT","IBBQ","SMI3.UK","BK4578","LU2098885051.SGD","LU2294711713.HKD","04332","BK4532","IE0002141913.USD","LU0868494617.USD","LU1983299246.USD","BK4076","LU0320765992.SGD","HODU","MSII","COIO","LU2242652126.USD","PJP","BK4023","IBAT","MSTY.UK","LU0122379950.USD","LU2543165471.USD","07711","ICLN","LU0823414478.USD","09399","MSTR","SMST","07799","BITQ","LU1642822529.SGD","MSTC","BK4558","09711","BK4516","LU1571399168.USD","PBE","LU1815336760.USD","BK4600","IBB","LU0889565916.HKD","BK4596","MSTY","COIX","HOYY","LU2112291526.USD","09311","COIA","COIG","LU2360107671.USD","STYL","HOOZ","BIB","LU0823411888.USD","LMI3.UK","09799","LU0786609619.USD","LU1064131342.USD","IE00BFTCPJ56.SGD","3SMI.UK","MSDD","SG9999001440.SGD","LU1267930573.SGD","HOOC","HOOD","BK4139","MSTU","LU0708994859.HKD","MSTP","TBXU","LU0320765489.SGD","LU1861559042.SGD","OWNB","COYY","MST","LU0058720904.USD","VCLN","ROBN","VTWG","LU0128525929.USD","CONY","BPAY","SMOG","HOOW","BK4541","BK4535","CONI","IE00B4R5TH58.HKD","MSOO","UPGR","HOII","3LMI.UK","LU0128525689.USD","SIMS","MSTW","BLCK","BK4539","IE0009354923.USD","BK4551","LU0823414551.USD","COII","07311","CNRG","IE00BYQQ9H92.USD","LU0109394709.USD","BBH","LU0476273544.USD","LU1267930227.SGD","GMEC","LU2468319806.SGD","LU1988902786.USD","FIAT","COIN","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125754221","title":"Pharmaceutical Giant's Shares Plunge Nearly 10% Following Triple Clinical Trial Setbacks","url":"https://stock-news.laohu8.com/highlight/detail?id=1125754221","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125754221?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:00","pubTimestamp":1788858037,"startTime":"0","endTime":"0","summary":"Swiss pharmaceutical heavyweight Novartis faced a turbulent trading session on Tuesday as its shares tumbled sharply following the disclosure that its experimental drug for muscular dystrophy,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211331839.USD","BK4585","MDTX","BMED","BK4532","IE00BJT1NW94.SGD","NVS","BK4578","LU0070302665.USD","MEDX","IE00B2B36J28.USD","IE0002141913.USD","BK4007","PSYK","IE00BJJMRZ35.SGD","BK4588","IBBQ","PPH","IE00B4R5TH58.HKD","LU0208291251.USD","LU0320765489.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179120005","title":"Medprin Regenerative Medical Technologies Advances Absorbable Hemostatic Gel to Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1179120005","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179120005?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:28","pubTimestamp":1788856093,"startTime":"0","endTime":"0","summary":"Medprin Regenerative Medical Technologies Co., Ltd. (301033.SZ) has officially announced that its research project involving the \"absorbable hemostatic fluid gelatin\" has recently entered the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDTX","301033","IBBJ","IBBQ","BK0251","PSYK","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665230393","title":"Amgen Shares Down 5.4% Premarket; Rival Novartis Cholesterol Drug Fails Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2665230393","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665230393?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:27","pubTimestamp":1788856044,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4500JB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBH","IE00BFTCPJ56.SGD","LU0058720904.USD","LU2468319806.SGD","LU0889565916.HKD","PJP","IE00BJT1NW94.SGD","LU0109394709.USD","IE00BJJMRZ35.SGD","PBE","LU1057294990.SGD","TBXU","LU0868494617.USD","IE0002141913.USD","IE0009355771.USD","IBBQ","IE00B4R5TH58.HKD","LU2242652126.USD","BK4534","LU1023059063.AUD","IBB","BK4588","IE00B2B36J28.USD","BIB","LU0320765992.SGD","BK4581","LU1061106388.HKD","LU2112291526.USD","LU0289739699.SGD","LU1571399168.USD","AMGN","BK4533","BK4585","LU2242646821.SGD","LU0122379950.USD","BK4139","LU1983299246.USD","SG9999001440.SGD","BK4566","BK4599","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665532340","title":"Why the Dow is Being Dragged Down by a Swiss Company's Bad News","url":"https://stock-news.laohu8.com/highlight/detail?id=2665532340","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665532340?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:15","pubTimestamp":1788855300,"startTime":"0","endTime":"0","summary":"Bad news from Swiss pharmaceutical giant Novartis was weighing on the Dow on Tuesday.Investors returning from the Labor Day break could be forgiven for wondering if their eyes were deceiving them, but","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","AMGN","BK4007","LU1061106388.HKD","BK4566","IE00B4R5TH58.HKD","LU0208291251.USD","NVS","IE00BFTCPJ56.SGD","BK4585","MEDX","LU1023059063.AUD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU0320765489.SGD","BK4532","LU0058720904.USD","LU2468319806.SGD","IBB","LU0070302665.USD","BK4533","LU0122379950.USD","IE00B2B36J28.USD","BK4139","NAMS","LU0868494617.USD","LU1983299246.USD","BK4588","LU2112291526.USD","IE0002141913.USD","LU2242652126.USD","BBH","IBBQ","BK4581","IE0009355771.USD","LU0211331839.USD","LU1057294990.SGD","LU1571399168.USD","PJP","PPH","LU0289739699.SGD","SG9999001440.SGD","LU0320765992.SGD","BK4534","LU2089984988.USD","PBE","LU0109394709.USD","BK4578","BK4599","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665101723","title":"Milton Essex boosts Sanford Biotech capital to drive advanced mastitis cell therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2665101723","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665101723?lang=en_us&edition=fundamental","pubTime":"2026-09-08 02:47","pubTimestamp":1788806848,"startTime":"0","endTime":"0","summary":"MILTON ESSEX S.A. ( ($PL:MTN) ) just unveiled an announcement. Milton Essex S.A., acting as sole shareholder of Sanford Biotech, has approved a PLN...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/milton-essex-boosts-sanford-biotech-capital-to-drive-advanced-mastitis-cell-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/milton-essex-boosts-sanford-biotech-capital-to-drive-advanced-mastitis-cell-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MTNmain","GNOM","BK4588","LFSC","BK4585","FBT","BK4581","SYNB","XBI","IBB","TBXU","IBBQ","CNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665317041","title":"Gilead Sciences (GILD) Receives a Buy from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2665317041","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665317041?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:25","pubTimestamp":1788798346,"startTime":"0","endTime":"0","summary":"Bernstein analyst Courtney Breen maintained a Buy rating on Gilead Sciences today and set a price target of $160.00. Breen covers the Healthcare se...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-receives-a-buy-from-bernstein-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-receives-a-buy-from-bernstein-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","LU2468319806.SGD","BK4581","XBI","BMED","LU1037948541.HKD","LU1778281490.HKD","LU2089984988.USD","IE0002270589.USD","GILD","IE00B7SZLL34.SGD","IBB","LU1839511570.USD","LU0122379950.USD","XLV","LU0965508806.USD","LU0823416689.USD","LU1585245621.USD","SG9999015945.SGD","IE00BZ1G4Q59.USD","LU2112291526.USD","LU1934455277.USD","LU1066051498.USD","IE00B3T34201.USD","BK4550","LU1571399168.USD","LU1934455863.HKD","BK4578","BK4566","BK4588","LU0882574055.USD","SG9999015978.USD","LU1674673428.USD","LU0289739699.SGD","LABU","IE00B19Z3B42.SGD","LU2324357040.USD","BIB","BK4139","BBH","BK4585","SG9999015952.SGD","TBXU","IBBQ","IE00BKVL7J92.USD","IE00BSNM7G36.USD","LU0114720955.EUR","TMED","LU1934455194.USD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106718626","title":"Jiangsu Aidea Pharmaceutical to Join Specialised Earnings Briefing for Innovative Drug Firms on STAR Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1106718626","media":"Deep News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106718626?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:51","pubTimestamp":1788781895,"startTime":"0","endTime":"0","summary":"Jiangsu Aidea Pharmaceutical Group Co., Ltd. (688488) has disclosed its intention to participate in a collective earnings presentation tailored for the innovative drug sector on the STAR Market,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","KSTR","159992","BK0262","688488","IBBQ","LNGR","BK1574","MEDX","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199113939","title":"CSPC Pharma Initiates Phase II Trial of SYH2085 Tablet for Uncomplicated Influenza in Chinese Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=1199113939","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199113939?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:36","pubTimestamp":1788780985,"startTime":"0","endTime":"0","summary":"CSPC Pharma (01093) has announced that the Phase II clinical trial of its SYH2085 tablet, designed for the treatment of uncomplicated influenza in adults, has formally commenced at the first clinical...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1226287792.SGD","LU1807302812.USD","LU1951186391.HKD","IE00B5MMRT66.SGD","LU1152091168.USD","IE00BZ08YR35.GBP","SG9999004220.SGD","LU1813983027.USD","LU1226287875.USD","LU0880133367.SGD","LU1226288170.HKD","KURE","IBBJ","IE00BZ08YS42.EUR","IE00B031HY20.USD","LU1008478684.HKD","BMED","BK1191","BK1521","LU1960683339.HKD","LU0501845795.SGD","01093","LU0140636845.USD","LU0072913022.USD","MDTX","IE00BZ08YT58.USD","BK1515","IE00B543WZ88.USD","LU2039709279.SGD","HK0000165453.HKD","PSYK","LU1328277881.USD","LU0067412154.USD","IBBQ","LU0314109678.HKD","LU0315179316.USD","LU1226287529.USD","LU0326950275.SGD","IE0008368742.USD","LU1152091754.HKD","IE0008369823.USD","LU1993786604.SGD","LU1226288253.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143231072","title":"Remegen Announces Participation in Nasdaq-Style STAR Market Biopharma Sector Earnings Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1143231072","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143231072?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:20","pubTimestamp":1788780027,"startTime":"0","endTime":"0","summary":"Remegen Co., Ltd. announced on September 7 that it will join the collective earnings communication session for the innovative drug industry on the STAR Market for the first half of 2026, scheduled...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131003.USD","BK1574","LU2328871848.SGD","LNGR","BK1583","BK0239","LU2148510915.USD","688331","09995","LU1969619763.USD","LU1064130708.USD","159992","06978","BK1161","IBBQ","MEDX","LU2488822045.USD","KSTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187160052","title":"HENGRUI PHARMA Advances Pipeline with SHR-1179 Injection Clinical Trial Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1187160052","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187160052?lang=en_us&edition=fundamental","pubTime":"2026-09-07 18:52","pubTimestamp":1788778333,"startTime":"0","endTime":"0","summary":"Hengrui Pharma (01276) has announced that its subsidiary, Guangdong Hengrui Pharmaceutical Co., Ltd., has recently received the \"Drug Clinical Trial Approval Notice\" issued by the National Medical...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0405327494.USD","MDTX","LU1328615791.USD","LU2289578879.USD","BK0012","BMED","BK0060","LU2580892862.HKD","LU2580892789.USD","IBBQ","LU0359201885.HKD","LU0359201612.USD","LU2097828714.EUR","LU1064131003.USD","LU1255011170.USD","LU1781817850.SGD","BK0188","LU1064130708.USD","LU1146622755.USD","LU1580142542.USD","LU2543165471.USD","BK0028","LU1969619763.USD","600276","01276","BK0196","LU1655091616.SGD","LU0359202008.SGD","LU2097828631.EUR","PSYK","BK0183","LU1997245177.USD","LU2097828557.USD","LU2488822045.USD","LU1023057109.AUD","LU2097828474.EUR","LU2495084118.USD","BK0239","IBBJ","BK1191","LU1997245094.SGD","LU0405327148.USD","LU1820825898.SGD","LU2328871848.SGD","LU1997244956.HKD","LU2097828805.USD","LU2148510915.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110897642","title":"Hengrui Pharma Subsidiary Gains Clinical Trial Approval for Weight Management Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1110897642","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110897642?lang=en_us&edition=fundamental","pubTime":"2026-09-07 17:22","pubTimestamp":1788772938,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SH: 600276) has announced that its subsidiary, Shandong Shengdi Pharmaceutical Co., Ltd., recently received the Drug Clinical Trial Approval Notice issued...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2543165471.USD","BK0060","LU2580892789.USD","LU1328615791.USD","BK0239","LU0359202008.SGD","LU2289578879.USD","LU0405327494.USD","LU2097828631.EUR","LU1997245094.SGD","LU1781817850.SGD","LU2328871848.SGD","LU0359201612.USD","BK0012","LU1255011170.USD","LU2097828557.USD","IBBQ","LU1997245177.USD","LU2495084118.USD","LU1820825898.SGD","LU1655091616.SGD","LU1064130708.USD","BK1191","LU2097828474.EUR","LU2488822045.USD","LU1969619763.USD","LU2148510915.USD","BK0028","LU0405327148.USD","LU1023057109.AUD","LU0359201885.HKD","600276","BK0196","LU2097828805.USD","LU1997244956.HKD","LU1146622755.USD","01276","BK0188","BK0183","BMED","LU1064131003.USD","MDTX","IBBJ","PSYK","LU1580142542.USD","LU2097828714.EUR","LU2580892862.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176376860","title":"Chongqing Zhifei Biological Receives Clinical Trial Approval for Recombinant Rotavirus Subunit Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1176376860","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176376860?lang=en_us&edition=fundamental","pubTime":"2026-09-07 17:20","pubTimestamp":1788772824,"startTime":"0","endTime":"0","summary":"Chongqing Zhifei Biological Products Co.,Ltd. (300122.SZ) has announced that its wholly-owned subsidiary, Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd., has obtained a drug clinical trial approval...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","BMED","BK0188","BK0046","159646","BK0196","IBBQ","LU1064130708.USD","BK0077","BK0239","LU2148510915.USD","PSYK","LU2580892789.USD","MDTX","LU1064131003.USD","IBBJ","LU2580892862.HKD","300122"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}